236 related articles for article (PubMed ID: 21160463)
1. ANCA-associated glomerulonephritis in the very elderly.
Bomback AS; Appel GB; Radhakrishnan J; Shirazian S; Herlitz LC; Stokes B; D'Agati VD; Markowitz GS
Kidney Int; 2011 Apr; 79(7):757-64. PubMed ID: 21160463
[TBL] [Abstract][Full Text] [Related]
2. ANCA comes of age-but with caveats.
Hamour SM; Salama AD
Kidney Int; 2011 Apr; 79(7):699-701. PubMed ID: 21403654
[TBL] [Abstract][Full Text] [Related]
3. Glomerular Immune Deposition in MPO-ANCA Associated Glomerulonephritis Is Associated With Poor Renal Survival.
Lin W; Shen C; Zhong Y; Ooi JD; Eggenhuizen P; Zhou YO; Luo H; Huang J; Chen JB; Wu T; Meng T; Xiao Z; Ao X; Peng W; Tang R; Yin H; Xiao X; Zhou Q; Xiao P
Front Immunol; 2021; 12():625672. PubMed ID: 33841408
[TBL] [Abstract][Full Text] [Related]
4. ANCA positive crescentic glomerulonephritis outcome in a Central East European cohort: a retrospective study.
Andreiana I; Stancu S; Avram A; Taran L; Mircescu G
BMC Nephrol; 2015 Jun; 16():90. PubMed ID: 26123651
[TBL] [Abstract][Full Text] [Related]
5. ANCA renal risk score predicts outcome in the Manchester cohort.
Li AS; Saleh C; Denley H; Patel M; Brix SR
Kidney Int; 2019 Jul; 96(1):246-247. PubMed ID: 31229033
[No Abstract] [Full Text] [Related]
6. Predictors of Renal Outcomes in Sclerotic Class Anti-Neutrophil Cytoplasmic Antibody Glomerulonephritis.
Menez S; Hruskova Z; Scott J; Cormican S; Chen M; Salama AD; Alasfar S; Little MA; Safrankova H; Honsova E; Tesar V; Geetha D
Am J Nephrol; 2018; 48(6):465-471. PubMed ID: 30472700
[TBL] [Abstract][Full Text] [Related]
7. Antineutrophil cytoplasmic antibody negative pauci-immune extracapillary glomerulonephritis.
Villacorta J; Diaz-Crespo F; Acevedo M; Guerrero C; Mollejo M; Fernandez-Juarez G
Nephrology (Carlton); 2016 Apr; 21(4):301-7. PubMed ID: 26369898
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Microscopic Hematuria after Induction of Remission in Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis.
Vandenbussche C; Bitton L; Bataille P; Glowacki F; Azar R; Hatron PY; Macnamara E; Gheerbrant JD; Cardon G; Hoffmann M; Auxenfants E; Gnemmi V; Quéméneur T
Am J Nephrol; 2019; 49(6):479-486. PubMed ID: 31117066
[TBL] [Abstract][Full Text] [Related]
9. Pauci-immune glomerulonephritis in children: a clinicopathologic study of 21 patients.
Khalighi MA; Wang S; Henriksen KJ; Bock M; Keswani M; Chang A; Meehan SM
Pediatr Nephrol; 2015 Jun; 30(6):953-9. PubMed ID: 25669759
[TBL] [Abstract][Full Text] [Related]
10. Pauci-immune glomerulonephritis: does negativity of anti-neutrophilic cytoplasmic antibodies matters?
Sharma A; Nada R; Naidu GS; Minz RW; Kohli HS; Sakhuja V; Gupta KL; Rathi M
Int J Rheum Dis; 2016 Jan; 19(1):74-81. PubMed ID: 26269223
[TBL] [Abstract][Full Text] [Related]
11. ANCA-positive pauci-immune rapidly progressive glomerulonephritis and the nephrotic syndrome.
Jabur WL; Saeed HM
Saudi J Kidney Dis Transpl; 2010 May; 21(3):526-30. PubMed ID: 20427883
[TBL] [Abstract][Full Text] [Related]
12. On ANCA-associated glomerulonephritis in the very elderly.
Reschen ME
Kidney Int; 2011 Nov; 80(10):1107; author reply 1107. PubMed ID: 22042032
[No Abstract] [Full Text] [Related]
13. A historical study of American patients with anti-neutrophil cytoplasmic antibody negative pauci-immune glomerulonephritis.
Shah S; Havill J; Rahman MH; Geetha D
Clin Rheumatol; 2016 Apr; 35(4):953-60. PubMed ID: 26445939
[TBL] [Abstract][Full Text] [Related]
14. Clinical prognostic factors of renal outcome in anti-neutrophil cytoplasmic autoantibody (ANCA)-associated glomerulonephritis in elderly patients.
Kaplan-Pavlovcic S; Cerk K; Kveder R; Lindic J; Vizjak A
Nephrol Dial Transplant; 2003 Jul; 18 Suppl 5():v5-7. PubMed ID: 12817057
[TBL] [Abstract][Full Text] [Related]
15. M2 macrophage infiltrates in the early stages of ANCA-associated pauci-immune necrotizing GN.
Zhao L; David MZ; Hyjek E; Chang A; Meehan SM
Clin J Am Soc Nephrol; 2015 Jan; 10(1):54-62. PubMed ID: 25516918
[TBL] [Abstract][Full Text] [Related]
16. Clinical, serological and histological determinants of patient and renal outcome in ANCA-associated vasculitis with renal involvement: an analysis from a referral centre.
Crnogorac M; Horvatic I; Toric L; Galesic Ljubanovic D; Tisljar M; Galesic K
Int Urol Nephrol; 2017 Aug; 49(8):1419-1431. PubMed ID: 28646482
[TBL] [Abstract][Full Text] [Related]
17. A cohort study to investigate sex-specific differences in ANCA-associated glomerulonephritis outcomes.
Scott J; Canepa C; Buettner A; Ryan L; Moloney B; Cormican S; Walsh C; White A; Salama AD; Little MA
Sci Rep; 2021 Jun; 11(1):13080. PubMed ID: 34158593
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear.
Walsh M; Casian A; Flossmann O; Westman K; Höglund P; Pusey C; Jayne DR;
Kidney Int; 2013 Aug; 84(2):397-402. PubMed ID: 23615499
[TBL] [Abstract][Full Text] [Related]
19. Outcome Predictors of Biopsy-Proven Myeloperoxidase-Anti-Neutrophil Cytoplasmic Antibody-Associated Glomerulonephritis.
Ge Y; Yang G; Yu X; Sun B; Zhang B; Yuan Y; Zeng M; Wang N; Mao H; Xing C
Front Immunol; 2020; 11():607261. PubMed ID: 33613528
[TBL] [Abstract][Full Text] [Related]
20. Increase of Antimyeloperoxidase Antineutrophil Cytoplasmic Antibody (ANCA) in Patients with Renal ANCA-associated Vasculitis: Association with Risk to Relapse.
Yamaguchi M; Ando M; Kato S; Katsuno T; Kato N; Kosugi T; Sato W; Tsuboi N; Yasuda Y; Mizuno M; Ito Y; Matsuo S; Maruyama S
J Rheumatol; 2015 Oct; 42(10):1853-60. PubMed ID: 26373560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
